Passer au contenu principal

Alpha-N-acetylgalactosaminidase deficiency

Alpha-N-acetylgalactosaminidase deficiency, also known as Schindler disease, is an inherited disorder that can affect the development of the nervous system. People with alpha-N-acetylgalactosaminidase deficiency often have distinctive facial features that can be described as "coarse" and tooth abnormalities such as widely-spaced teeth and missing teeth (hypodontia).

Description

Alpha-N-acetylgalactosaminidase deficiency, also known as Schindler disease, is an inherited disorder that can affect the development of the nervous system. People with alpha-N-acetylgalactosaminidase deficiency often have distinctive facial features that can be described as "coarse" and tooth abnormalities such as widely-spaced teeth and missing teeth (hypodontia).

The three types of alpha-N-acetylgalactosaminidase deficiency differ in the severity of their signs and symptoms and the age at which they first appear. The signs and symptoms of alpha-N-acetylgalactosaminidase deficiency can vary, even among members of the same family. 

Type I is the most severe form of this condition. Babies with alpha-N-acetylgalactosaminidase deficiency type I appear healthy at birth. However, by late infancy, these babies typically have trouble meeting normal developmental milestones. By the age of 2 years, individuals with type I begin to lose skills that they had already acquired (developmental regression). Individuals with type I often experience weak muscle tone (hypotonia), vision and hearing loss, and seizures. During early childhood, children with type I typically lose awareness of their surroundings and eventually become unresponsive.

Alpha-N-acetylgalactosaminidase deficiency type II is the least severe form. Type II is typically diagnosed in adulthood. Affected individuals may have mild cognitive impairment and hearing loss caused by abnormalities of the inner ear (sensorineural hearing loss). They may also experience a loss of sensation or muscle weakness in the extremities (peripheral neuropathy). Clusters of enlarged blood vessels that form small, dark red spots on the skin (angiokeratomas) are a characteristic feature of alpha-N-acetylgalactosaminidase deficiency type II.

Type III is the intermediate form of alpha-N-acetylgalactosaminidase deficiency. People with type III may show a variety of signs and symptoms, including developmental, speech, and language delays; seizures that begin in infancy; and features of autism spectrum disorder that appear in childhood. Autism spectrum disorder is characterised by impaired communication and socialization skills. People with type III may also have skeletal signs and symptoms, such as pain in the lower back, hips, and knees. Wear on the cartilage (disks) and bones of the neck (cervical spondylosis) and a cyst-like collection of cerebrospinal fluid that forms in the spinal cord (syringohydromyelia) have also been reported.

Inheritance patterns

The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.

Other names

Alpha-galactosidase B deficiency

Alpha-galNAc deficiency, Schindler type

Alpha-N-acetylgalactosaminidase deficiency

Alpha-NAGA deficiency

Angiokeratoma corporis diffusum-glycopeptiduria

GALB deficiency

Kanzaki disease

Lysosomal glycoaminoacid storage disease-angiokeratoma corporis diffusum

NAGA deficiency type I

NAGA deficiency type II

NAGA deficiency type III

Neuroaxonal dystrophy, Schindler type

Neuronal axonal dystrophy, Schindler type

Schindler disease type I

Schindler disease type II

Schindler disease type III

Related patient information and medicines

Tests de fonction hépatique

Patient information leaflet

Tests de fonction hépatique

Tests de fonction hépatique are a set of sang tests commonly done to check on the health of your liver. Changes in liver function tests give a clue as to whether your liver is under strain, inflamed, infected or diseased, and how badly. The pattern of the liver function tests can give a clue to the cause and can allow early detection of unsuspected.

Insuffisance hépatique

Patient information leaflet

Insuffisance hépatique

Diseases of the veins in the liver Some diseases (for example, Budd-Chiari syndrom... Metabolic diseases Some rare metabolic diseases may cause acute liver failure. These include haemochromatosis Haemochromatosis , alpha-1 antitrypsin deficiency Alpha-1 antitrypsine deficiency , Wilson's disease Wilson's disease , fructose intolerance,.

Syndrome des jambes sans repos

Patient information leaflet

Syndrome des jambes sans repos

No treatment may be needed if symptom... Medication can ease symptoms if the condition is distressing. What is restless legs syndrome. Restless legs syndrome (RLS) is sometimes called Willis-Ekbom disease after the doctors who first described it. It is a condition where you have an urge to move your legs. This is usually caused by an uncomfortable.

Malabsorption gastro-intestinale

Patient information leaflet

Malabsorption gastro-intestinale

Gastrointestinal malabsorption syndrome means a failure to fully absorb digested aliments from the gut (bowel) into your body. There are many different causes. Prolonged intestinal malabsorption may cause problems because of a lack of carbohydrates, proteins, fats, minerals and vitamins that are essential to keep you healthy. The treatment will.

Bronchectasie

Patient information leaflet

Bronchectasie

Bronchectasie is a problem with the lungs, where you cough up lots of phlegm, (sputum): far more than usual. It is usually caused by something that has already affected the lungs, like a bad infection; but sometimes no cause is found. It generally affects older people. There are some good treatments available to keep it under control..

Puis-je prendre de l'acide folique et de la glucosamine ensemble ?

Patient information leaflet

Puis-je prendre de l'acide folique et de la glucosamine ensemble ?

It is generally considered safe to take these two supplements together. Why this happens Folic acid (a B vitamin) and glucosamine (an amino sugar) are processed by the body through different pathways. They do not compete for absorption in the gut, nor do they interfere with how the liver breaks down or the kidneys remove each substance. Our.

Lectures complémentaires et références

Historique de l'article

Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
  • 14 mars 2025 | Dernière version
  • 1 mars 2025 | Publié à l'origine

Participez à la conversation

Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.

Avertissement : The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Pharmacie en ligne, traitements et services de santé

Accès simple à des traitements fiables et à des services de santé en ligne.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Inscrivez-vous à la newsletter Patient

Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.

Veuillez entrer une adresse e-mail valide

En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.